What is a clinical trial? Is participating in a clinical trial right for you? Learn more
Hypertrophic Cardiomyopathy With Obstruction Clinical Trial in Barcelona
Have you or your loved ones been diagnosed with hypertrophic cardiomyopathy with obstruction?
You may be eligible to participate in a hypertrophic cardiomyopathy with obstruction clinical trial.
Have you or your loved ones been diagnosed with hypertrophic cardiomyopathy with obstruction? You may be eligible to participate in a hypertrophic cardiomyopathy with obstruction clinical trial.
Active not recruiting
Male & Female
18 Years +
This investigation is a prospective, randomized, single-blinded and multicenter design. The purpose of this study is to evaluate the benefit of atrial-synchronous biventricular (BiV) pacing in severely symptomatic hypertrophic obstructive cardiomyopathy (HOCM) patients with severe Left Ventricular Outflow Tract (LVOT) obstruction implanted with a Cardiac Resynchronization Therapy - Pacing (CRT-P) device. Randomization - Implant will be performed (CRT-P). - Patients will be randomized 1:1 to either Treatment Group (Optimized Biventricular (DDD) pacing) or Control Group (Back-up Atrial (AAI) pacing) during the first 12 months: - Treatment Group. The patient´s device is programmed to optimized DDD BiV pacing - Control Group. The patient´s device is programmed to back-up pacing AAI. - After 12 months, the patients initially randomized to the Treatment Group (Optimized DDD Pacing) will continue in the same group. The patients initially randomized to Control Group (AAI Back-up Pacing) will be changed to the Treatment Group (Optimized DDD Pacing). And all the patients will be followed 12 months more.